253 related articles for article (PubMed ID: 26876154)
21. The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation.
Altuntas S; Rossin F; Marsella C; D'Eletto M; Diaz-Hidalgo L; Farrace MG; Campanella M; Antonioli M; Fimia GM; Piacentini M
Oncotarget; 2015 Dec; 6(42):44941-54. PubMed ID: 26702927
[TBL] [Abstract][Full Text] [Related]
22. Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism.
Guridi M; Kupr B; Romanino K; Lin S; Falcetta D; Tintignac L; Rüegg MA
Skelet Muscle; 2016; 6():13. PubMed ID: 27004103
[TBL] [Abstract][Full Text] [Related]
23. Effects of combining rapamycin and resveratrol on apoptosis and growth of TSC2-deficient xenograft tumors.
Alayev A; Salamon RS; Sun Y; Schwartz NS; Li C; Yu JJ; Holz MK
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):637-46. PubMed ID: 25844891
[TBL] [Abstract][Full Text] [Related]
24. AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth.
Park YS; Kim DJ; Koo H; Jang SH; You YM; Cho JH; Yang SJ; Yu ES; Jung Y; Lee DC; Kim JA; Park ZY; Park KC; Yeom YI
Oncotarget; 2016 Jul; 7(30):48155-48167. PubMed ID: 27340866
[TBL] [Abstract][Full Text] [Related]
25. Chemical manipulation of the mTORC1 pathway in industrially relevant CHOK1 cells enhances production of therapeutic proteins.
Dadehbeigi N; Dickson AJ
Biotechnol J; 2015 Jul; 10(7):1041-50. PubMed ID: 26059164
[TBL] [Abstract][Full Text] [Related]
26. Mammalian target of rapamycin complex 2 (mTORC2) regulates LPS-induced expression of IL-12 and IL-23 in human dendritic cells.
Wei WC; Liu CP; Yang WC; Shyur LF; Sheu JH; Chen SS; Yang NS
J Leukoc Biol; 2015 Jun; 97(6):1071-80. PubMed ID: 25877925
[TBL] [Abstract][Full Text] [Related]
27. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
Shao H; Gao C; Tang H; Zhang H; Roberts LR; Hylander BL; Repasky EA; Ma WW; Qiu J; Adjei AA; Dy GK; Yu C
J Hepatol; 2012 Jan; 56(1):176-83. PubMed ID: 21835141
[TBL] [Abstract][Full Text] [Related]
28. The PtdIns3-phosphatase MTMR3 interacts with mTORC1 and suppresses its activity.
Hao F; Itoh T; Morita E; Shirahama-Noda K; Yoshimori T; Noda T
FEBS Lett; 2016 Jan; 590(1):161-73. PubMed ID: 26787466
[TBL] [Abstract][Full Text] [Related]
29. IKK interacts with rictor and regulates mTORC2.
Xu Y; Lai E; Liu J; Lin J; Yang C; Jia C; Li Y; Bai X; Li M
Cell Signal; 2013 Nov; 25(11):2239-45. PubMed ID: 23872070
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
[TBL] [Abstract][Full Text] [Related]
31. PKM2-mediated inhibition of autophagy facilitates Tat's inducing HIV-1 transactivation.
Zhang HS; Zhang ZG; Zhou Z; Du GY; Li H; Yu XY; Huang YH
Arch Biochem Biophys; 2017 Jul; 625-626():17-23. PubMed ID: 28583828
[TBL] [Abstract][Full Text] [Related]
32. Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity.
Faes S; Demartines N; Dormond O
Oxid Med Cell Longev; 2017; 2017():1726078. PubMed ID: 28280521
[TBL] [Abstract][Full Text] [Related]
33. High glucose up
Tang L; Xu Y; Liu X; Chen R; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):305-313. PubMed ID: 32386023
[TBL] [Abstract][Full Text] [Related]
34. PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation.
Li T; Han J; Jia L; Hu X; Chen L; Wang Y
Protein Cell; 2019 Aug; 10(8):583-594. PubMed ID: 30887444
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of PKM2 promotes mitochondrial fusion through attenuated p53 stability.
Wu H; Yang P; Hu W; Wang Y; Lu Y; Zhang L; Fan Y; Xiao H; Li Z
Oncotarget; 2016 Nov; 7(47):78069-78082. PubMed ID: 27801666
[TBL] [Abstract][Full Text] [Related]
36. Non-metabolic functions of glycolytic enzymes in tumorigenesis.
Yu X; Li S
Oncogene; 2017 May; 36(19):2629-2636. PubMed ID: 27797379
[TBL] [Abstract][Full Text] [Related]
37. Spatio-Temporal Parameters of Endosomal Signaling in Cancer: Implications for New Treatment Options.
Stasyk T; Huber LA
J Cell Biochem; 2016 Apr; 117(4):836-43. PubMed ID: 26506511
[TBL] [Abstract][Full Text] [Related]
38. Cell signalling: A peroxisomal home for TSC.
David R
Nat Rev Mol Cell Biol; 2013 Oct; 14(10):609. PubMed ID: 24002222
[No Abstract] [Full Text] [Related]
39. STRIPAK complexes in cell signaling and cancer.
Shi Z; Jiao S; Zhou Z
Oncogene; 2016 Sep; 35(35):4549-57. PubMed ID: 26876214
[TBL] [Abstract][Full Text] [Related]
40. Correction: Inhibition of mTORC1 Kinase Activates Smads 1 and 5 but Not Smad8 in Human Prostate Cancer Cells, Mediating Cytostatic Response to Rapamycin.
Mol Cancer Res; 2018 Jan; 16(1):184. PubMed ID: 29191929
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
